← Acquirers
Has LivTech approached you? Here’s what to do.
Acquirer profile
Who is LivTech?
LivTech is a private equity firm.
Firm facts
LivTech
- Type
- private equity firm
- Website
- livtech.com
- Backed by
- PSG Equity
- Previously backed by
- Greater Sum Ventures
Industries
Last verified 2026-10-30
How they work
LivTech provides clinical, operational, billing and payment technology for senior and post-acute care. It acquired Alora Healthcare Systems in April 2026, adding home-health software to its offering. Its physician division includes ChartPath, PUREDI and Sertus.
LivTech acquired Alora to combine home-health clinical software with its wider operating platform. The reviewed official sources do not publish financial acquisition thresholds or a standard seller process.
- Sector focus
- Senior-care and post-acute healthcare technology, including electronic health records, home care, clinical operations and revenue-cycle management.
Their portfolio
Showing 5 of 5 known holdings — coverage is still partial.
Company
Sector
What they do
- Alora Healthcare SystemsSectorHealthcareWhat they doCloud-based home-health software provider acquired by LivTech in April 2026, adding clinical and AI-enhanced EMR capabilities.
- SectorHealthcareWhat they doElectronic health record software for physicians and nurse practitioners rounding in skilled nursing and post-acute care settings.
- SectorHealthcareWhat they doSenior-living software connecting clinical records, medication administration, billing and community operating data.
- PUREDISectorHealthcareWhat they doRevenue-cycle and billing services business in LivTech’s physician division.
- SertusSectorHealthcareWhat they doHealthcare technology business named within LivTech’s physician division; a more specific independently verified product description remains to be established.
Want updates related to acquisitions?
Sources
- livtech.com · portfolio page
- livtech.com · website
- livtech.com · research
- chartpath.com · research
- eldermark.com · research
- livtech.com · research
The truth, first.Data as at 2026-10-30